Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BCL2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
B-cell lymphoma 2 - anti-apoptotic protein critical for neuronal survival in neurodegeneration
| Gene Symbol | BCL2 |
| Aliases | B-cell lymphoma 2 |
| Protein Family | BCL-2 family (anti-apoptotic subfamily) |
| Function | Direct BAX/BAK inhibition |
| Molecular Weight | 26 kDa |
| Pathways | Akt, Apoptosis, Autophagy, BMP signaling, Bh4 Domain |
| UniProt ID | P10415 |
| GeneCards | BCL2 |
| Human Protein Atlas | BCL2 |
| BH3 domain | Required for interaction with pro-apoptotic family members |
| Transmembrane domain | Anchors BCL2 to the outer mitochondrial membrane, ER, and nuclear envelope |
| BH1 domain | Forms part of the hydrophobic pocket that binds BH3 domains |
| BH2 domain | Contributes to the binding interface for pro-apoptotic proteins |
| N-terminal flexible region | Contains regulatory sequences |
| Phosphorylation | BCL2 is phosphorylated on multiple serine/threonine residues |
| Associated Diseases | AD, ALI, ALS, AUTOPHAGY, Aging |
| Known Drugs/Compounds | RAPAMYCIN, BERBERINE, R-PE, cadmium, magnolol, Tirzepatide |
| Interactions | LMNA, STING1, TAX1BP1, ATM, SNCAIP, RB1CC1 |
| KG Connections | 2784 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
BCL2["BCL2"] -->|"expressed in"| MITOCHONDRIA["MITOCHONDRIA"]
BCL2["BCL2"] -.->|"inhibits"| BECN1["BECN1"]
BCL2["BCL2"] -->|"interacts"| Dementia["Dementia"]
BCL2["BCL2"] -->|"interacts"| Cardiovascular["Cardiovascular"]
BCL2["BCL2"] -->|"interacts"| Als["Als"]
BCL2["BCL2"] -->|"interacts"| Alzheimer["Alzheimer"]
STAT3["STAT3"] -->|"regulates"| BCL2["BCL2"]
BMAL1["BMAL1"] -->|"regulates"| BCL2["BCL2"]
CAT["CAT"] -->|"interacts"| BCL2["BCL2"]
OPTN["OPTN"] -->|"interacts"| BCL2["BCL2"]
style BCL2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| CASP3 | associated_with | gene | 1.00 |
| Cancer | inhibits | disease | 1.00 |
| Apoptosis | inhibits | pathway | 1.00 |
| Leukemia | inhibits | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Leukemia | therapeutic_target | disease | 1.00 |
| Apoptosis | therapeutic_target | pathway | 1.00 |
| Als | activates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Cancer | regulates | disease | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| CANCER | inhibits | gene | 1.00 |
| Lymphoma | activates | disease | 1.00 |
| AKT | therapeutic_target | gene | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| Intrinsic Apoptosis | regulates | pathway | 0.98 |
| AMBRA1 | binds | protein | 0.95 |
| Cytochrome C Release | regulates | process | 0.95 |
| chronic lymphocytic leukaemia | therapeutic_target | disease | 0.95 |
| chronic lymphocytic leukemia | therapeutic_target | disease | 0.95 |
| cancer | therapeutic_target | disease | 0.95 |
| cell survival | regulates | process | 0.95 |
| cytochrome c release | regulates | process | 0.95 |
| Cytochrome C | regulates | protein | 0.95 |
| Als | inhibits | disease | 0.95 |
| Lymphoma | associated_with | disease | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| acute myeloid leukemia | therapeutic_target | disease | 0.92 |
| acute myeloid leukemia | biomarker_for | disease | 0.92 |
| Mitochondrial Outer Membrane Permeabilization | causes | process | 0.90 |
| Macroautophagy | inhibits | process | 0.90 |
| BECLIN1 | binds | protein | 0.90 |
| IP3R | binds | protein | 0.90 |
| retinal cell death | protects_against | process | 0.90 |
| cancer cell death | inhibits | process | 0.90 |
| mantle cell lymphoma | therapeutic_target | disease | 0.90 |
| diffuse large B-cell lymphoma | associated_with | disease | 0.90 |
| intrinsic apoptosis pathway | upstream_of | pathway | 0.90 |
| proapoptotic proteins | interacts_with | protein | 0.90 |
| Mitochondrial Apoptosis | regulates | process | 0.90 |
| apoptosis | inhibits | phenotype | 0.90 |
| apoptosis | regulates | phenotype | 0.90 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | associated_with | gene | 1.00 |
| APOPTOSIS | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | disease | 1.00 |
| TP53 | interacts_with | protein | 1.00 |
| T3 (triiodothyronine) | increases | drug | 0.95 |
| venetoclax | inhibits | drug | 0.95 |
| ABT263 | inhibits | drug | 0.95 |
| Cyclosporine A | downregulates | drug | 0.92 |
| HB68 | downregulates | compound | 0.92 |
| HB147 | downregulates | compound | 0.92 |
| gallic acid | associated_with | drug | 0.90 |
| R-phycoerythrin | associated_with | drug | 0.90 |
| CTSG | inhibits | protein | 0.90 |
| Abt263 | inhibits | drug | 0.90 |
| Venetoclax | inhibits | drug | 0.90 |
| BH3-Mimetics | targets | compound | 0.90 |
| venetoclax | binds_to | drug | 0.90 |
| sonrotoclax | binds_to | drug | 0.90 |
| Rotenone | downregulates | compound | 0.90 |
| Bh3-Mimetics | targets | compound | 0.90 |
| cardamom nanoemulsion | downregulates | compound | 0.90 |
| STAT3 | activates | gene | 0.90 |
| PI3K | therapeutic_target | gene | 0.90 |
| PI3K | activates | gene | 0.90 |
| PI3K | regulates | protein | 0.90 |
| OXIDATIVE STRESS | activates | gene | 0.90 |
| JAK2/STAT3 Signaling Pathway | upregulates | pathway | 0.88 |
| BCL-xL | coexpressed_with | protein | 0.87 |
| MCL1 | coexpressed_with | protein | 0.87 |
| melamine | downregulates | compound | 0.87 |
| BMAL1 | upregulates | gene | 0.85 |
| LYPLAL1-DT | activates | gene | 0.85 |
| BPF | binds_to | drug | 0.85 |
| miR-195 | downregulates | gene | 0.85 |
| TP53 | binds_to | protein | 0.85 |
| SQDS | upregulates | drug | 0.85 |
| sonrotoclax | inhibits | drug | 0.85 |
| lisaftoclax | inhibits | drug | 0.85 |
| Bisphenol F | binds | compound | 0.85 |
| Nomilin | binds | compound | 0.85 |
| Protacs | targets | compound | 0.85 |
| Adcs | targets | compound | 0.85 |
| HB147 | targets | compound | 0.85 |
| AKR1B10 | regulates | gene | 0.85 |
| Oxidative Stress | downregulates | process | 0.85 |
| BAX | associated_with | gene | 0.82 |
| LRWE | regulates | drug | 0.80 |
| R-PE | inhibits | drug | 0.80 |
| MTOR | activates | protein | 0.80 |
| BAX | regulates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||